Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $22.0800 (-2.3%) ($21.7900 - $22.9300) on Fri. Jun. 7, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.32% (three month average) | RSI | 42 | Latest Price | $22.0800(-2.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(49%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.16% in a week (0% probabilities). VXX(-34%) TLT(-13%) UNG(-6%) IFRA(-5%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.16% (StdDev 4.32%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
Resistance Level | $23.55 | 5 Day Moving Average | $23.07(-4.29%) | 10 Day Moving Average | $22.92(-3.66%) | 20 Day Moving Average | $23.55(-6.24%) | To recent high | -46.2% | To recent low | 0% | Market Cap | $1.641b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |